These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Nosocomial bacterial pneumonia in HIV-infected patients: risk factors for adverse outcome and implications for rational empiric antibiotic therapy. Franzetti F; Grassini A; Piazza M; Degl'innocenti M; Bandera A; Gazzola L; Marchetti G; Gori A Infection; 2006 Feb; 34(1):9-16. PubMed ID: 16501896 [TBL] [Abstract][Full Text] [Related]
7. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Chung DR; Song JH; Kim SH; Thamlikitkul V; Huang SG; Wang H; So TM; Yasin RM; Hsueh PR; Carlos CC; Hsu LY; Buntaran L; Lalitha MK; Kim MJ; Choi JY; Kim SI; Ko KS; Kang CI; Peck KR; Am J Respir Crit Care Med; 2011 Dec; 184(12):1409-17. PubMed ID: 21920919 [TBL] [Abstract][Full Text] [Related]
8. Challenges in the design and conduct of clinical trials for hospital-acquired pneumonia and ventilator-associated pneumonia: an industry perspective. Barriere SL Clin Infect Dis; 2010 Aug; 51 Suppl 1():S4-9. PubMed ID: 20597670 [TBL] [Abstract][Full Text] [Related]
9. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance. Werarak P; Kiratisin P; Thamlikitkul V J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567 [TBL] [Abstract][Full Text] [Related]
10. [Bacterial etiology of nosocomial pneumonia and antimicrobial resistance in patients with and without antimicrobial treatment]. Weyland B; Perazzi B; García S; Rodríguez C; Vay C; Famiglietti A Rev Argent Microbiol; 2011; 43(1):18-23. PubMed ID: 21491061 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study. Chastre J; Wunderink R; Prokocimer P; Lee M; Kaniga K; Friedland I Crit Care Med; 2008 Apr; 36(4):1089-96. PubMed ID: 18379232 [TBL] [Abstract][Full Text] [Related]
12. End points in hospital-acquired pneumonia and/or ventilator-associated pneumonia clinical trials: food and drug administration perspective. Laessig KA Clin Infect Dis; 2010 Aug; 51 Suppl 1():S117-9. PubMed ID: 20597659 [TBL] [Abstract][Full Text] [Related]
13. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series. Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994 [TBL] [Abstract][Full Text] [Related]
14. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967 [TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials. Jenkins SG; Fisher AC; Peterson JA; Nicholson SC; Kaniga K Curr Med Res Opin; 2009 Dec; 25(12):3029-36. PubMed ID: 19849650 [TBL] [Abstract][Full Text] [Related]